PharmaCyte Biotech

Yahoo Finance • last year

Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech

- $6.85 million upfront investment provides $23 million total cash runway into second half 2025 - - Financing allows for focused commercial team to bring Femasys’ infertility-related products to women in the U.S. - - Additional financing... Full story